These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32075836)

  • 21. A feasibility study evaluating the uptake, effectiveness and acceptability of routine screening of pregnant migrants for latent tuberculosis infection in antenatal care: a research protocol.
    Rahman A; Thangaratinam S; Copas A; Zenner D; White PJ; Griffiths C; Abubakar I; McCourt C; Kunst H
    BMJ Open; 2022 Apr; 12(4):e058734. PubMed ID: 35379641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cohort Study of Pulmonary Tuberculosis (COSMOTB) identifying drug-resistant mutations: protocol for a prospective observational study in Korea.
    Min J; Chung C; Lim J; Park JH; Shin KS; Jung SS; Lee KM
    BMJ Open; 2018 Oct; 8(10):e021235. PubMed ID: 30309990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of a large latent tuberculous infection screening programme using QuantiFERON
    Hwang HJ; Park JH; Nam S; Lee HJ; Kim HJ; Yu S; Shin SY
    Int J Tuberc Lung Dis; 2018 May; 22(5):504-509. PubMed ID: 29663954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study.
    Ronald LA; Campbell JR; Rose C; Balshaw R; Romanowski K; Roth DZ; Marra F; Schwartzman K; Cook VJ; Johnston JC
    Clin Infect Dis; 2019 Nov; 69(12):2101-2108. PubMed ID: 30856258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions.
    Villa S; Codecasa LR; Faccini M; Pontello MM; Ferrarese M; Castellotti PF; Senatore S; Lamberti A; Mazzola E; Perno CF; Campisi D; Saporiti M; Raviglione MC
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31413161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
    PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings.
    van Geuns D; Arts RJW; de Vries G; Wit FWNM; Degtyareva SY; Brown J; Pareek M; Lipman M; van Crevel R
    AIDS; 2024 Feb; 38(2):193-205. PubMed ID: 37991008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study.
    Spruijt I; Tesfay Haile D; Suurmond J; van den Hof S; Koenders M; Kouw P; van Noort N; Toumanian S; Cobelens F; Goosen S; Erkens C
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31537698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial.
    Oxlade O; Trajman A; Benedetti A; Adjobimey M; Cook VJ; Fisher D; Fox GJ; Fregonese F; Hadisoemarto P; Hill PC; Johnston J; Long R; Obeng J; Ruslami R; Valiquette C; Menzies D
    BMJ Open; 2019 Mar; 9(3):e025831. PubMed ID: 30898826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.
    Wingate LT; Coleman MS; de la Motte Hurst C; Semple M; Zhou W; Cetron MS; Painter JA
    BMC Public Health; 2015 Dec; 15():1201. PubMed ID: 26627449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cascade of care for latent tuberculosis infection in congregate settings: A national cohort analysis, Korea, 2017-2018.
    Min J; Kim HW; Stagg HR; Rangaka MX; Lipman M; Abubakar I; Lee Y; Myong JP; Jeong H; Bae S; Shin AY; Kang JY; Lee SS; Park JS; Yim HW; Kim JS
    Front Med (Lausanne); 2022; 9():927579. PubMed ID: 36186763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries.
    Cui X; Gao L; Cao B
    Int J Infect Dis; 2020 Mar; 92S():S37-S40. PubMed ID: 32114201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden and predictors of latent tuberculosis infection among immigrants in South Korea: a retrospective cross-sectional study.
    Yu S; Jeong D; Choi H
    BMC Infect Dis; 2021 Dec; 21(1):1206. PubMed ID: 34861855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection.
    Lee EH; Kang YA; Leem AY; Park MS; Kim YS; Kim SK; Chang J; Kim SY
    Sci Rep; 2017 Jul; 7(1):6473. PubMed ID: 28743918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of latent tuberculosis infection rate between contacts with active tuberculosis and non-contacts.
    Yoo JW; Jo KW; Park GY; Shim TS
    Respir Med; 2016 Feb; 111():77-83. PubMed ID: 26725461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and determinants of latent tuberculosis infection among frontline tuberculosis healthcare workers in southeastern China: A multilevel analysis by individuals and health facilities.
    Chen B; Gu H; Wang X; Wang F; Peng Y; Ge E; Upshur R; Dai R; Wei X; Jiang J
    Int J Infect Dis; 2019 Feb; 79():26-33. PubMed ID: 30471404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of latent tuberculosis screening in HIV care centres: evaluation in a low tuberculosis incidence setting.
    Wyndham-Thomas C; Schepers K; Dirix V; Mascart F; Van Vooren JP; Goffard JC
    Epidemiol Infect; 2016 Mar; 144(4):703-11. PubMed ID: 26211466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries.
    Padmapriyadarsini C; Sachdeva KS; Nair D; Ramachandran R
    Expert Rev Respir Med; 2021 Jul; 15(7):899-910. PubMed ID: 33302729
    [No Abstract]   [Full Text] [Related]  

  • 40. Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study.
    Berrocal-Almanza LC; Harris R; Lalor MK; Muzyamba MC; Were J; O'Connell AM; Mirza A; Kon OM; Lalvani A; Zenner D
    Lancet Infect Dis; 2019 Nov; 19(11):1191-1201. PubMed ID: 31471131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.